Pfizer said it would ask regulators to greenlight a vaccine designed to protect infants against respiratory syncytial virus, or RSV, following strong results in late-stage clinical trials.
Pharma giant Pfizer on Tuesday said it would ask regulators to greenlight a vaccine designed to protect infants against respiratory syncytial virus, or RSV, following strong results in late-stage clinical trials, a potential gamechanger in efforts to combat the common but potentially lethal infection as cases soar and children’s hospitals struggle to cope....
The shot was nearly 82% effective at preventing a severe form of lower respiratory tract illness from RSV during the baby’s first 90 days of life, Pfizer said, and about 70% effective over the first six months.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsPfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.
Leer más »
RSV Vaccine Protected Infants From Severe Cases, Pfizer Study FindsAn RSV vaccine given to pregnant women significantly reduced the risk of severe cases in their infants. The study comes as doctors report unusually high numbers of the respiratory illness.
Leer más »
Pfizer announces promising developments for 1st maternal RSV vaccineAfter decades of researching respiratory syncytial virus, an illness especially dangerous for newborns and the elderly, scientists this week announced a major development in plans for a possible vaccine that could be available as soon as next year.
Leer más »
Pfizer to seek regulatory approval as strong RSV vaccine data lifts hopesThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Leer más »
RSV Vaccine Given During Pregnancy Protects Newborns: PfizerNew trial data from drugmaker Pfizer shows promising effectiveness of a vaccine given to mothers during pregnancy that later protects infants in their first months from the most devastating effects of respiratory syncytial virus, or RSV.
Leer más »
Pfizer Says Its Maternal RSV Vaccine Can Protect Newborns From Severe IllnessPfizer announced Tuesday that a large international study found vaccinating moms-to-be was nearly 82% effective at preventing severe cases of RSV in their babies’ most vulnerable first 90 days of life.
Leer más »